Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
Open | $4.32 |
Close | $4.36 |
Volume / Avg. | 2.03M / 2.28M |
Day Range | $4.21 - $4.46 |
52 Wk Range | 2.83 - 23.52 |
Market Cap | $308.61M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 68 |
Short Interest | 34.85% |
Days to Cover | 16.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Zentalis Pharma has a consensus price target of $20.10.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $4.34 last updated September 19, 2024 at 6:42 PM EDT.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.